These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 16553807

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation.
    Benito JM, Lopez M, Lozano S, Ballesteros C, Capa L, Martinez P, Gonzalez-Lahoz J, Soriano V.
    J Infect Dis; 2005 Dec 15; 192(12):2142-6. PubMed ID: 16288380
    [Abstract] [Full Text] [Related]

  • 23. Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
    Beran O, Holub M, Spála J, Kalanin J, Stanková M.
    Acta Virol; 2003 Dec 15; 47(2):121-4. PubMed ID: 14524479
    [Abstract] [Full Text] [Related]

  • 24. Correlation of T-lymphocyte subpopulations with immunological markers in HIV-1-infected Indian patients.
    Kaushik S, Vajpayee M, Sreenivas V, Seth P.
    Clin Immunol; 2006 Jun 15; 119(3):330-8. PubMed ID: 16476571
    [Abstract] [Full Text] [Related]

  • 25. Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial.
    Gori A, Trabattoni D, Bandera A, Saresella M, Marchetti G, Gazzola L, Biasin M, Rhodes J, McDade H, Panebianco R, Galli M, Moroni M, Ferrante P, Thomas N, Franzetti F, Bray D, Clerici M.
    Antivir Ther; 2004 Aug 15; 9(4):603-14. PubMed ID: 15456092
    [Abstract] [Full Text] [Related]

  • 26. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T, Brouwer M, Girma M, Fontanet AL, Miedema F, Hamann D, Rinke de Wit TF.
    Clin Immunol; 2001 Feb 15; 98(2):212-9. PubMed ID: 11161977
    [Abstract] [Full Text] [Related]

  • 27. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.
    Benveniste O, Flahault A, Rollot F, Elbim C, Estaquier J, Pédron B, Duval X, Dereuddre-Bosquet N, Clayette P, Sterkers G, Simon A, Ameisen JC, Leport C.
    J Infect Dis; 2005 May 15; 191(10):1670-9. PubMed ID: 15838794
    [Abstract] [Full Text] [Related]

  • 28. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M, Soriano V, Rallón N, Cascajero A, González-Lahoz J, Benito JM.
    Eur J Immunol; 2008 Jun 15; 38(6):1548-58. PubMed ID: 18421792
    [Abstract] [Full Text] [Related]

  • 29. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN, Shang H, Jiang YJ, Liu J, Dai D, Diao YY, Geng WQ, Jin X, Wang YN.
    Chin Med J (Engl); 2006 Dec 05; 119(23):1966-71. PubMed ID: 17199940
    [Abstract] [Full Text] [Related]

  • 30. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
    Méndez-Lagares G, Pozo-Balado MM, Genebat M, García Pergañeda A, Leal M, Pacheco YM.
    J Infect Dis; 2012 May 15; 205(10):1501-9. PubMed ID: 22457273
    [Abstract] [Full Text] [Related]

  • 31. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM, López M, Lozano S, González-Lahoz J, Soriano V.
    J Infect Dis; 2008 Nov 15; 198(10):1466-73. PubMed ID: 18847371
    [Abstract] [Full Text] [Related]

  • 32. Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression.
    Zhang JC, Zhang HJ, Li Y, Jing D, Liu Q, Zhao K, Liu QQ, Zhuang Y, Kang WZ, Sun YT.
    Scand J Infect Dis; 2013 May 15; 45(5):368-77. PubMed ID: 23186319
    [Abstract] [Full Text] [Related]

  • 33. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART.
    Marziali M, De Santis W, Carello R, Leti W, Esposito A, Isgrò A, Fimiani C, Sirianni MC, Mezzaroma I, Aiuti F.
    AIDS; 2006 Oct 24; 20(16):2033-41. PubMed ID: 17053349
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Restoration of Toxoplasma gondii-specific immune responses in patients with AIDS starting HAART.
    Furco A, Carmagnat M, Chevret S, Garin YJ, Pavie J, De Castro N, Charron D, Derouin F, Rabian C, Molina JM.
    AIDS; 2008 Oct 18; 22(16):2087-96. PubMed ID: 18832872
    [Abstract] [Full Text] [Related]

  • 37. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS, Foxall RB, Cortesão CS, Soares RS, Doroana M, Ribeiro A, Lucas M, Antunes F, Victorino RM, Sousa AE.
    Clin Immunol; 2007 Oct 18; 125(1):67-75. PubMed ID: 17692571
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection.
    Streeck H, Jessen H, Alter G, Teigen N, Waring MT, Jessen A, Stahmer I, van Lunzen J, Lichterfeld M, Gao X, Allen TM, Carrington M, Walker BD, Rockstroh JK, Altfeld M.
    J Infect Dis; 2006 Sep 15; 194(6):734-9. PubMed ID: 16941338
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.